Abstract
BackgroundThe use of pattern recognition receptor agonists (PRRAs) such as Toll-like receptor (TLR) agonists is an attractive approach for cancer immunotherapy. TLR agonism elicits anti-tumor activity by activating antigen presenting...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have